INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2017

A ketogenic diet reduced seizure frequency and severity in pediatric intractable epilepsy compared to usual care, but cost per QALY was inconclusive.

Children and adolescents with intractable epilepsy were randomized to a ketogenic diet (KD) or care as usual (CAU) and followed for 16 months. In total, 58% of the KD group completed follow-up (11 dropped out). At 16 months, 35% of KD participants achieved a seizure reduction of ≥50% from baseline versus 18% in the CAU group, and 46.2% reported decreased worst seizure severity versus 32% in CAU. Mean per-patient costs were €61,019 in the KD group compared with €53,367 (extrapolated) in CAU, giving an ICER of €46,564 per responder. The KD group had significantly more gastrointestinal issues at 4 months but fewer at 16 months compared to CAU; cost per QALY ratios were inconclusive due to minimal QALY differences.

Study type
Randomized controlled trial
Who was studied
48 children and adolescents with intractable epilepsy (26 in the ketogenic diet group)
What was measured
Seizure frequency and severity, retention rate, QALYs, side effects, and health care/societal costs over 16 months

THE PAPER

Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy.

Wijnen BFM, de Kinderen RJA, Lambrechts DAJE, Postulart D, Aldenkamp AP, Majoie MHJM, Evers SMAA. Epilepsy Res, 2017.

PubMed 28364726 ↗DOI 10.1016/j.eplepsyres.2017.03.002 ↗

Gut & microbiomeBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.